To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SLIT2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
201 supporting clones for gene SLIT2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AB017168   .a 1 to 4950 1 to 4950 exact tiling clone,   4950/4950
(100 %)
4 diff
(100.0 %id)
NM_004787.1   .a 1 to 4950 1 to 4950 exact RefSeq,   4950/4950
(100 %)
4 diff
(100.0 %id)
BC117190 Pooled,bladder, uterus, placenta, PCRrescued clones .a 126 to 4819 1 to 4694 exact tiling clone,   4694/4694
(100 %)
0 diff
(100 %id)
BP311899 brain .a 1119 to 1700 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AK308444 uterus .a 1333 to 3734 1 to 2402       2402/2402
(100 %)
4 diff
(99.9 %id)
DC422644 uterus .a 1333 to 1888 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
DA859786 placenta .a 1374 to 1929 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB225781 trachea .a 1377 to 1944 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB218245 trachea .a 1412 to 1889 2 to 480   capped   479/479
(100 %)
2 diff
(99.6 %id)
DA733312   .a 1477 to 2254 2 to 780   capped   779/848
(91 %)
13 diff
(98.5 %id)
DB365209   .a 4374 to 4951 580 to 1   tiling clone,   580/582
(99 %)
18 diff
(97.0 %id)
AF133270 brain .b 1 to 4735 1 to 4735 Q226K tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 4735/4735
(100 %)
2 diff
(100.0 %id)
DA312087 hippocampus .b 324 to 847 19 to 542   capped   524/541
(96 %)
6 diff
(98.9 %id)
BP247544 Kidney .b 403 to 994 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
DA403651 thalamus .b 418 to 959 2 to 544   tiling clone, capped   543/545
(99 %)
6 diff
(98.9 %id)
CN286535 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 544 to 926 400 to 18     Submitted on the opposite strand 384/400
(96 %)
1 diff
(99.8 %id)
AK027326 whole embryo, mainly head .b 3015 to 4735 1 to 1721   available from FLJ,   1721/1721
(100 %)
1 diff
(100.0 %id)
DA570864 whole embryo, mainly head .b 3016 to 3834 2 to 822   capped   821/837
(98 %)
2 diff
(99.8 %id)
AA486867 lung .b 3625 to 3798 1 to 171       171/171
(100 %)
3 diff
(98.3 %id)
BG218202   .b 3832 to 4643 1 to 811       811/811
(100 %)
37 diff
(95.5 %id)
TI_149284979   .b 3839 to 4762 955 to 51       905/1187
(76 %)
27 diff
(97.8 %id)
TI_149289006   .b 3926 to 4762 886 to 56       831/913
(91 %)
18 diff
(98.1 %id)
TI_149293186   .b 3926 to 4762 888 to 59       830/1060
(78 %)
11 diff
(99.0 %id)
BQ015028 Chondrosarcoma, Left Pubic Bone .b 4006 to 4735 747 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 729/731
(99 %)
4 diff
(99.5 %id)
CN479579 Chondrosarcoma, Left Pubic Bone .b 4013 to 4735 737 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 719/719
(100 %)
4 diff
(99.5 %id)
AW029356 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 4054 to 4735 670 to 1       670/670
(100 %)
13 diff
(98.1 %id)
BU682523 lung .b 4064 to 4735 690 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 672/672
(100 %)
1 diff
(99.9 %id)
BM988628 lung, Metastatic Chondrosarcoma .b 4068 to 4735 686 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 668/668
(100 %)
1 diff
(99.9 %id)
AW190464 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 4075 to 4736 661 to 1       661/661
(100 %)
9 diff
(98.7 %id)
BM984625 lung .b 4122 to 4735 630 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 612/616
(99 %)
4 diff
(99.4 %id)
BM970707 lung .b 4122 to 4735 632 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 614/614
(100 %)
0 diff
(100 %id)
BE223051 brain, oligodendroglioma .b 4132 to 4735 603 to 1       603/603
(100 %)
2 diff
(99.7 %id)
AI434815 Kidney .b 4135 to 4735 601 to 1       601/601
(100 %)
3 diff
(99.6 %id)
TI_154003348   .b 4135 to 4756 714 to 93       622/714
(87 %)
6 diff
(99.2 %id)
DB357671 whole embryo, mainly head .b 4136 to 4735 599 to 1       599/599
(100 %)
10 diff
(98.4 %id)
AI955702 adenocarcinoma, Pancreas .b 4141 to 4735 595 to 1       595/595
(100 %)
2 diff
(99.7 %id)
AW264567 brain, three pooled meningiomas .b 4150 to 4743 594 to 1       594/594
(100 %)
1 diff
(99.9 %id)
BM091516 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .b 4162 to 4734 574 to 1       574/574
(100 %)
6 diff
(99.0 %id)
TI_1320132193   .b 4184 to 4609 1 to 424       424/1240
(34 %)
11 diff
(99.2 %id)
TI_2194632334   .b 4192 to 4605 13 to 426       414/606
(68 %)
7 diff
(98.9 %id)
AI312093 lung .b 4228 to 4734 507 to 1       507/507
(100 %)
1 diff
(99.9 %id)
AI379631 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 4228 to 4735 508 to 1       508/508
(100 %)
1 diff
(99.9 %id)
AI418415 pooled .b 4231 to 4734 504 to 1       504/504
(100 %)
3 diff
(99.5 %id)
AA992746   .b 4243 to 4739 496 to 1       496/496
(100 %)
4 diff
(99.2 %id)
R78732 placenta .b 4249 to 4735 497 to 1       497/501
(99 %)
20 diff
(96.1 %id)
AW263423 brain, three pooled meningiomas .b 4267 to 4737 470 to 1       470/470
(100 %)
6 diff
(98.8 %id)
AW517525 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 4294 to 4746 455 to 1       453/455
(99 %)
5 diff
(99.0 %id)
AI340286 lung .b 4305 to 4734 430 to 1       430/430
(100 %)
1 diff
(99.8 %id)
AI417035 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 4305 to 4742 438 to 1       438/438
(100 %)
1 diff
(99.8 %id)
AA844303 parathyroid gland, parathyroid tumor .b 4313 to 4735 425 to 1       425/426
(99 %)
8 diff
(98.2 %id)
AA621350   .b 4332 to 4739 408 to 1       408/411
(99 %)
0 diff
(100 %id)
AI690653 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 4345 to 4742 396 to 1       396/396
(100 %)
3 diff
(99.3 %id)
AW294515   .b 4349 to 4735 404 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 387/387
(100 %)
1 diff
(99.8 %id)
CA433363 mixed .b 4402 to 4735 352 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 334/334
(100 %)
1 diff
(99.8 %id)
AI381263   .b 4437 to 4735 299 to 1       299/299
(100 %)
1 diff
(99.7 %id)
AI823331 Kidney .b 4441 to 4735 295 to 1       295/298
(98 %)
3 diff
(99.0 %id)
AA894634 Kidney .b 4450 to 4735 286 to 1       286/286
(100 %)
3 diff
(99.0 %id)
AA486868 lung .b 4492 to 4735 244 to 1       244/244
(100 %)
1 diff
(99.6 %id)
DA683807   .c 1 to 670 2 to 673   tiling clone, capped   672/672
(100 %)
4 diff
(99.5 %id)
DA721496   .c 1 to 309 2 to 310   tiling clone, capped   309/309
(100 %)
0 diff
(100 %id)
DA721992   .c 2 to 560 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB023565 testis .c 2 to 541 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA857577 placenta .c 5 to 548 2 to 546   capped   545/545
(100 %)
4 diff
(99.3 %id)
CN255800 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 11 to 564 1 to 554   tiling clone,   554/554
(100 %)
4 diff
(99.3 %id)
CN255801 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 14 to 587 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
AW235958 Kidney .c 140 to 476 339 to 1       339/339
(100 %)
5 diff
(98.6 %id)
AW300525 Kidney .c 202 to 476 275 to 1       275/275
(100 %)
1 diff
(99.7 %id)
AI796050 Kidney .c 529 to 961 1 to 433     Submitted on the opposite strand 433/433
(100 %)
3 diff
(99.4 %id)
BF445938 breast, invasive ductal carcinoma, 3 pooled samples .c 532 to 1073 1 to 542   tiling clone, Submitted on the opposite strand 542/542
(100 %)
2 diff
(99.7 %id)
AA022570 heart .c 556 to 787 1 to 228     Submitted on the opposite strand 228/228
(100 %)
9 diff
(96.1 %id)
H10953 whole brain .c 558 to 961 1 to 411     Submitted on the opposite strand 411/411
(100 %)
14 diff
(96.6 %id)
BP873446 embryonal kidney .c 618 to 1200 1 to 582       582/582
(100 %)
16 diff
(97.3 %id)
BP873457 embryonal kidney .c 618 to 1194 1 to 580   tiling clone,   580/581
(99 %)
16 diff
(97.3 %id)
TI_57180929   .c 1015 to 1875 28 to 870       843/870
(96 %)
6 diff
(99.4 %id)
BI769043 pooled lung and spleen .c 1020 to 1875 1 to 838   tiling clone,   838/838
(100 %)
80 diff
(90.5 %id)
AA022569 heart .c 1158 to 1456 302 to 1   tiling clone, Submitted on the opposite strand 302/302
(100 %)
17 diff
(94.4 %id)
AF055585 kidney; brain .c 1355 to 6587 1 to 5233 S599K L600P K601Q T602N L626M tiling clone,   5233/5233
(100 %)
7 diff
(99.9 %id)
BX097407 whole brain .c 1659 to 2161 532 to 29   tiling clone, Submitted on the opposite strand 504/532
(94 %)
1 diff
(99.9 %id)
H10952 whole brain .c 1756 to 2185 439 to 2     Submitted on the opposite strand 438/464
(94 %)
16 diff
(96.6 %id)
TI_2194628730   .c 1831 to 2949 84 to 1192       1109/1294
(85 %)
25 diff
(98.1 %id)
TI_2194631038   .c 1831 to 2901 86 to 1149       1064/1276
(83 %)
22 diff
(98.3 %id)
TI_2194631389   .c 1831 to 2714 281 to 1161     Submitted on the opposite strand 881/1258
(70 %)
20 diff
(98.5 %id)
TI_2194631981   .c 1831 to 2306 280 to 755     Submitted on the opposite strand 476/930
(51 %)
7 diff
(99.3 %id)
TI_1320132169   .c 1831 to 2305 625 to 151       475/1256
(37 %)
0 diff
(100 %id)
BC143978 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .c 1832 to 6501 1 to 4670 exact tiling clone,   4670/4670
(100 %)
0 diff
(100 %id)
DN990549 brain, whole brain .c 1838 to 2305 1 to 469       469/556
(84 %)
8 diff
(98.6 %id)
CN286536 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 2305 to 2867 7 to 569       563/569
(98 %)
7 diff
(98.8 %id)
TI_2194632328   .c 2306 to 2567 181 to 442       262/442
(59 %)
0 diff
(100 %id)
TI_2194632336   .c 2415 to 3085 14 to 684       671/684
(98 %)
12 diff
(98.3 %id)
BP285170 lung .c 2747 to 3333 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
TI_2194632338   .c 2781 to 3454 13 to 688       676/689
(98 %)
5 diff
(99.3 %id)
TI_2194632340   .c 2962 to 3630 13 to 684       672/684
(98 %)
9 diff
(98.7 %id)
DA188723 amygdala .c 3025 to 3574 2 to 551   capped   550/558
(98 %)
1 diff
(99.9 %id)
TI_2194632329   .c 3244 to 3963 1 to 724       724/724
(100 %)
16 diff
(97.8 %id)
CN286538 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 3347 to 3901 13 to 568       556/568
(97 %)
7 diff
(98.8 %id)
DB175558 kidney, tumor tissue .c 3377 to 3941 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA477862   .c 3500 to 4071 8 to 579   capped   572/578
(98 %)
0 diff
(100 %id)
BP284908 lung .c 3514 to 4095 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
TI_2194632331   .c 3542 to 4259 1 to 721       721/721
(100 %)
6 diff
(99.2 %id)
DA808304 brain .c 3584 to 4142 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA012021 adrenal gland .c 3641 to 4212 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
CN286539 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3679 to 4412 1 to 734       734/734
(100 %)
0 diff
(100 %id)
DA753184   .c 3856 to 4409 7 to 560   capped   554/559
(99 %)
6 diff
(99.0 %id)
TI_2194632333   .c 3879 to 4501 16 to 641       626/643
(97 %)
8 diff
(98.8 %id)
CN286534 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 3917 to 4550 19 to 652       634/652
(97 %)
7 diff
(99.0 %id)
TI_1320132183   .c 4014 to 5115 1120 to 16       1105/1264
(87 %)
9 diff
(99.3 %id)
TI_2194632335   .c 4110 to 4976 1 to 865       865/968
(89 %)
12 diff
(98.8 %id)
DB285597 uterus .c 4159 to 4664 2 to 508   capped   507/507
(100 %)
2 diff
(99.7 %id)
DA525220 brain .c 4216 to 4771 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BQ708856 Spleen .c 4271 to 5180 1 to 913       913/919
(99 %)
21 diff
(97.8 %id)
DA549485   .c 4285 to 4845 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB251322 uterus .c 4287 to 4803 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
DA744919   .c 4345 to 4933 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA709841   .c 4401 to 4950 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA550362   .c 4601 to 5137 2 to 538   capped   537/542
(99 %)
2 diff
(99.7 %id)
TI_2194632337   .c 4606 to 5221 28 to 644       617/646
(95 %)
11 diff
(98.3 %id)
CK004587 brain/CNS, Human Brain - Frontal Cortex .c 4747 to 5383 1 to 637       637/637
(100 %)
1 diff
(99.9 %id)
CX757066 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 4748 to 5493 1 to 746     Submitted on the opposite strand 746/746
(100 %)
0 diff
(100 %id)
TI_2194632339   .c 4851 to 5585 12 to 747       736/810
(90 %)
16 diff
(98.1 %id)
DB260875 uterus .c 4955 to 5524 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AL602435 human skeletal muscle .c 4977 to 5578 1 to 601       601/602
(99 %)
2 diff
(99.7 %id)
TI_1320132175   .c 5066 to 6191 1125 to 3       1123/1272
(88 %)
5 diff
(99.7 %id)
TI_2194632341   .c 5072 to 5815 15 to 758       744/765
(97 %)
7 diff
(99.1 %id)
BE799037 lung, small cell carcinoma .c 5091 to 5852 12 to 771       760/787
(96 %)
18 diff
(97.8 %id)
BP378897 uterus .c 5113 to 5686 1 to 570       570/570
(100 %)
7 diff
(98.8 %id)
DA034392   .c 5139 to 5669 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
TI_1320132171   .c 5204 to 6381 1176 to 5       1172/1251
(93 %)
14 diff
(98.9 %id)
CD106107 brain, Pituitary .c 5244 to 5804 27 to 597       571/932
(61 %)
18 diff
(98.1 %id)
BI458067 brain, hypothalamus .c 5298 to 5928 11 to 640       630/640
(98 %)
9 diff
(98.6 %id)
TI_2194632332   .c 5334 to 5962 10 to 638       629/640
(98 %)
8 diff
(98.8 %id)
CN286537 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 5344 to 5907 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
TI_2194631046   .c 5406 to 6503 1196 to 112       1088/1282
(84 %)
18 diff
(98.6 %id)
TI_2194629109   .c 5448 to 6503 1160 to 112       1043/1279
(81 %)
13 diff
(99.0 %id)
TI_1320131385   .c 5450 to 6507 1160 to 107       1054/1280
(82 %)
13 diff
(99.0 %id)
BM091211 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .c 5452 to 6035 1 to 583       583/583
(100 %)
7 diff
(98.8 %id)
AA249686   .c 5589 to 5722 1 to 128       128/128
(100 %)
9 diff
(93.0 %id)
H68588 nose, olfactory epithelium .c 5598 to 5916 1 to 322       322/420
(76 %)
9 diff
(97.9 %id)
TI_1320132179   .c 5611 to 6507 1 to 897       897/1287
(69 %)
13 diff
(99.0 %id)
TI_2194632330   .c 5639 to 6100 20 to 481       462/481
(96 %)
19 diff
(96.1 %id)
BG484345 lung .c 5660 to 6446 1 to 788       788/810
(97 %)
25 diff
(97.0 %id)
CX166540 human embryonic stem cells differentiated toan early endodermal cell type .c 5669 to 6427 1 to 759       759/759
(100 %)
1 diff
(99.9 %id)
BU147452 dorsal root ganglia .c 5704 to 6524 1 to 829       829/890
(93 %)
17 diff
(98.1 %id)
FN075356 breast carcinoma .c 5953 to 6052 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
BF350992 head_neck .c 6187 to 6351 17 to 182       163/197
(82 %)
8 diff
(96.0 %id)
BG023818 duodenal adenocarcinoma, cell line, small intestine .c 6199 to 6856 30 to 689       660/1044
(63 %)
37 diff
(96.5 %id)
H68231 nose, olfactory epithelium .c 6248 to 6553 308 to 1       308/319
(96 %)
7 diff
(97.9 %id)
DB207352 trachea .c 6344 to 6918 2 to 576   tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
BF724716 eye, Iris .c 6410 to 6783 1 to 374       374/374
(100 %)
1 diff
(99.8 %id)
BF112143 pooled .c 6664 to 7185 524 to 3   tiling clone,   522/524
(99 %)
0 diff
(100 %id)
CV370469 ovary .c 6714 to 7048 339 to 1   tiling clone, Submitted on the opposite strand 339/339
(100 %)
18 diff
(94.7 %id)
AA413399   .c 6950 to 7165 216 to 1     Submitted on the opposite strand 216/216
(100 %)
1 diff
(99.6 %id)
BX955154   .d 1 to 625 1 to 625   tiling clone,   625/625
(100 %)
0 diff
(100 %id)
DA140238 alzheimer cortex .d 544 to 1091 2 to 550   tiling clone, to resequence, capped   549/549
(100 %)
1 diff
(99.9 %id)
DB301247 alzheimer cortex .d 1833 to 2342 510 to 1   tiling clone, to resequence,   510/510
(100 %)
1 diff
(99.9 %id)
CA395227 eye, RPE/choroid .e 1 to 498 1 to 498   tiling clone,   498/498
(100 %)
0 diff
(100 %id)
AK126459 uterus .e 60 to 3006 1 to 2947 exact tiling clone, available from FLJ,   2947/2947
(100 %)
1 diff
(100.0 %id)
DB273323 uterus .e 61 to 596 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DB352055 uterus .e 2485 to 3006 522 to 1       522/522
(100 %)
2 diff
(99.7 %id)
BM554858 duodenal adenocarcinoma, cell line, small intestine .f 1 to 736 1 to 736 exact tiling clone, AAA   736/736
(100 %)
0 diff
(100 %id)
BX509816   .g 1 to 712 2 to 714 V32S P34A K35E G36R I37Y ... tiling clone,   714/714
(100 %)
1 diff
(99.9 %id)
DA755513   .h 1 to 537 9 to 545   capped   537/537
(100 %)
1 diff
(99.9 %id)
DA755659   .h 1 to 562 9 to 570 exact tiling clone, capped   562/562
(100 %)
0 diff
(100 %id)
DA185902 amygdala .i 1 to 373 2 to 374 R2M tiling clone, capped   373/533
(69 %)
2 diff
(99.7 %id)
AA489463   .j 1 to 395 399 to 5 H25N tiling clone,   395/402
(98 %)
4 diff
(99.1 %id)
AA557446 low-grade prostatic neoplasia, Prostate .j 268 to 390 1 to 123   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 123/123
(100 %)
0 diff
(100 %id)
BM474839 duodenal adenocarcinoma, cell line, small intestine .k-u 1 to 777 1 to 777 exact tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 777/777
(100 %)
1 diff
(99.9 %id)
BM474898 duodenal adenocarcinoma, cell line, small intestine .k-u 1 to 777 1 to 778 exact AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 778/778
(100 %)
2 diff
(99.8 %id)
AA629585 lung, lung carcinoma .k-u 128 to 532 405 to 2       404/405
(99 %)
0 diff
(100 %id)
BG211512   .k-u 131 to 775 1 to 643 S23F F37S N41T F42S Y45T ... AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 643/643
(100 %)
9 diff
(98.7 %id)
CN260580 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k-u 140 to 733 1 to 594 E12K     594/594
(100 %)
1 diff
(99.9 %id)
AA034210 uterus .k-u 148 to 331 1 to 185     Submitted on the opposite strand 185/185
(100 %)
1 diff
(99.5 %id)
AA897592 pooled .k-u 148 to 450 1 to 303     Submitted on the opposite strand 303/303
(100 %)
1 diff
(99.7 %id)
AA988924 carcinoid, lung .k-u 148 to 513 1 to 366     Submitted on the opposite strand 366/366
(100 %)
0 diff
(100 %id)
AI185293 lung .k-u 149 to 542 1 to 394     Submitted on the opposite strand 394/394
(100 %)
0 diff
(100 %id)
AI692523 carcinoid, lung .k-u 149 to 679 1 to 531     Submitted on the opposite strand 531/531
(100 %)
0 diff
(100 %id)
AA257003 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 150 to 554 1 to 405     Submitted on the opposite strand 405/405
(100 %)
2 diff
(99.6 %id)
AA953915 2 pooled tumors (clear cell type), Kidney .k-u 150 to 490 1 to 341     Submitted on the opposite strand 341/341
(100 %)
0 diff
(100 %id)
AI090970 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 150 to 346 1 to 197     Submitted on the opposite strand 197/197
(100 %)
1 diff
(99.5 %id)
AI927325 Kidney .k-u 150 to 607 1 to 458     Submitted on the opposite strand 458/458
(100 %)
4 diff
(99.2 %id)
AW268844 pooled .k-u 150 to 601 1 to 452     Submitted on the opposite strand 452/452
(100 %)
4 diff
(99.2 %id)
AW510972 pooled .k-u 151 to 551 1 to 401     Submitted on the opposite strand 401/401
(100 %)
4 diff
(99.1 %id)
AW262606 brain, three pooled meningiomas .k-u 177 to 780 603 to 1 L7I M36I     603/603
(100 %)
30 diff
(95.1 %id)
AI963304 adenocarcinoma, Pancreas .k-u 216 to 780 565 to 1 exact     565/660
(85 %)
7 diff
(99.0 %id)
BX099663 multiple sclerosis lesions .k-u 261 to 782 1 to 524 M15X     524/525
(99 %)
7 diff
(98.7 %id)
N46243 multiple sclerosis lesions .k-u 288 to 446 1 to 160   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 160/160
(100 %)
4 diff
(97.5 %id)
AW268902 pooled .k-u 296 to 778 485 to 3 exact     483/485
(99 %)
0 diff
(100 %id)
AA033694 uterus .k-u 328 to 781 459 to 1     Submitted on the opposite strand 459/459
(100 %)
6 diff
(98.7 %id)
BF942319 medullary carcinoma, thyroid .k-u 328 to 571 18 to 261     Submitted on the opposite strand 244/261
(93 %)
6 diff
(97.8 %id)
AA055019 heart .k-u 330 to 776 1 to 448 V32G M34D Q35A M36D F37V ...     448/448
(100 %)
1 diff
(99.8 %id)
AI086363 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 345 to 777 445 to 13 exact AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 433/433
(100 %)
0 diff
(100 %id)
AI088202 heart .k-u 370 to 780 411 to 1 exact tiling clone,   411/411
(100 %)
1 diff
(99.8 %id)
BI494498 cochlea, ear .k-u 382 to 777 8 to 403 exact AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 396/403
(98 %)
6 diff
(98.6 %id)
AA357860 lung .k-u 402 to 655 1 to 254       254/254
(100 %)
1 diff
(99.7 %id)
AA357900 lung .k-u 402 to 780 381 to 1 I27T F37X     381/397
(95 %)
7 diff
(98.3 %id)
BF939447 Prostate .k-u 404 to 777 374 to 1 E12K     374/374
(100 %)
1 diff
(99.8 %id)
AW072233 pooled .k-u 409 to 778 372 to 3 exact     370/372
(99 %)
0 diff
(100 %id)
N46244 multiple sclerosis lesions .k-u 416 to 777 374 to 13 T3X E47X fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 362/362
(100 %)
2 diff
(99.5 %id)
BG207901   .k-u 437 to 776 358 to 18 L2* AAA Submitted on the opposite strand 341/350
(97 %)
25 diff
(92.9 %id)
BE876256 large cell carcinoma, undifferentiated, lung .k-u 469 to 777 1 to 306 L5C L6C L7* AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 306/306
(100 %)
3 diff
(99.1 %id)
AA845944 Spleen .k-u 494 to 700 207 to 1 exact     207/207
(100 %)
1 diff
(99.6 %id)
AI090944 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 578 to 777 200 to 1       200/201
(99 %)
0 diff
(100 %id)
DA717587   .l 1 to 442 2 to 443 V45X tiling clone, capped   442/442
(100 %)
1 diff
(99.8 %id)
DW416260 Liver .m-u 1 to 293 17 to 310 exact tiling clone,   294/310
(94 %)
6 diff
(98.1 %id)
DB174066 kidney, tumor tissue Gene SLIT2, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB304123 brain Gene SLIT2, variant not shown              
DA204208 brain Gene SLIT2, variant not shown       capped      
H53571 liver and spleen Gene SLIT2, variant not shown              
H53892 liver and spleen Gene SLIT2, variant not shown              
H81302 liver and spleen Gene SLIT2, variant not shown              
H81356 liver and spleen Gene SLIT2, variant not shown              
AA055976 heart Gene SLIT2, variant not shown              
AA056004 heart Gene SLIT2, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI